Submission of compliance under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.03.2025
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Ltd) has submitted to BSE a quarterly compliance certificate under SEBI's Depository Regulations for the quarter ended 31 March 2025. The certificate, issued by the company's Registrar and Share Transfer Agent MAS Services Limited, confirms that all dematerialisation requests received from Depository Participants between 1 January and 31 March 2025 were processed and confirmed to the depositories within the mandated 15-day timeframe. It also confirms that physical share certificates received for dematerialisation were duly cancelled and the depository's name was updated in the company's register of members within the stipulated period. The filing is purely procedural and was submitted on 15 April 2025 by the Company Secretary.
This is a routine regulatory compliance filing with no material impact on the company's financials, operations, or share price. It simply evidences that the company's share transfer activities were handled in accordance with SEBI rules during the quarter.